wk3xW

disorder and alcohol use disorder: six-month outcome. J Am Psychoanal Assoc.
2009;57(1):199-205.
98 Arnevik E, Wilberg T, Urnes O, Johansen M, Monsen JT, Karterud S.
Psychotherapy for personality disorders: short-term day hospital psychotherapy
versus outpatient individual therapy - a randomized controlled study. Eur
Psychiatry. 2009;24(2):71-8.
99 Bousoño García M, Bobes García J, González-Quirós Corujo P. Tratamiento
psicofarmacológico. En: Prevención de las conductas suicidas y parasuicidas.
Barcelona: Masson; 1997.
100 Ros Montalbán S, Arranz Martí B, Peris Díaz MD. Aproximaciones
terapéuticas preventivas. En: En: Comportamientos suicidas Prevención y
tratamiento. Barcelona: Ars medica; 2004.
101 Ernst CL, Goldberg JF. Antisuicide Properties of Psychotropic Drugs: A
Critical Review. Harv Rev Psychiatry. 2004;12(1):14-41.
102 Yerevanian BI, Koek RJ, Mintz J, Akiskal HS. Bipolar pharmacotherapy
and suicidal behavior. Part 2: The impact of antidepressants. J Affect Disord.
2007;103(1-3):13-21.
103 Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini
RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J
Psychiatry. 2004;161(1):163-5.
104 Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J.
Decreased risk of suicides and attempts during long-term lithium treatment: a
meta-analytic review. Bipolar Disord. 2006;8(5 Pt 2):625-39.
105 Baldessarini RJ, Tondo L. Suicidal risk during treatment of bipolar
disorder patients with lithium versus anticonvulsants. Pharmacopsychiatry.
2009;42:72-5.
106 Lauterbach E, Felber W, Müller-Oerlinghausen B, Ahrens B, Bronisch T, Meyer
T, et al. Adjunctive lithium treatment in the prevention of suicidal behaviour
in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta
Psychiatr Scand. 2008;118:469-79.
107 Comité de Consenso de Catalunya en Terapéutica de los Trastornos Mentales.
Recomendaciones terapéuticas en los trastornso mentales. Conducta suicida.
3ª ed. Barcelona: Ars Medica; 2005.
108 Collins JC, McFarland BH. Divalproex, lithium and suicide among Medicaid
patients with bipolar disorder. J Affect Disord. 2008;107(1-3):23-8.
109 Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide
risk in bipolar disorder during treatment with lithium and divalproex. JAMA.
2003;290(11):1467-73.
110 Sondergard L, López AG, Andersen PK, Kessing LV. Mood-stabilizing
pharmacological treatment in bipolar disorders and risk of suicide. Bipolar
Disord. 2008;10(1):87-94.
111 Arana A, Wentworth CE, Ayuso-Mateos JL, Arellano FM. Suicide-related
events in patients treated with antiepileptic drugs. NEJM. 2010;363(6):542-51.
112 FDA US Food and Drug Administration. Antiepileptic Drugs. Rockville (MD):
FDA; 2008 [citado 21 sep 2010]. Disponible en: http://www.fda.gov/Safety/
MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/
ucm074939.htm
Guía de Práctica Clínica de Prevención y Tratamiento de la Conducta Suicida 191